AUSPEX—Auspex Pharmaceuticals (NASDAQ:ASPX), a clinical stage company, is a pioneer in the targeted application of deuterium to clinically validated drugs with the goal of imparting greater efficacy and safety over existing agents and has secured a proprietary position on more than 180 compounds across a wide range of therapeutic areas. The pipeline of drug candidates addresses a number of therapeutic areas, including inflammation, anti-infectives, pain and other CNS areas.